C1 Technology Solutions

Enable rapid gene discovery. Accelerate product development. Bring gene products to market faster. Dyadic’s proprietary C1 technology is used for gene discovery, host optimization, large-scale manufacturing, and the creation of new products for diverse markets such as animal feed, pulp and paper, food, beverages, textiles, biofuels, biochemicals and biopharmaceuticals.

Learn More


Develop advanced dependable bioenergy solutions. Identify novel enzymes that convert biomass into fermentable sugars for use in producing biofuels. Bring more cost-effective alternative fuel solutions to market faster. Dyadic’s C1 technology creates new development opportunities, through licensing arrangements and partnerships.

Learn More


Break the bottlenecks in your genomic research and development programs. Accelerate product development. Improve production yields. Dyadic is interested in forming strategic partnerships to discover biomaterials, lower your costs, develop new products and bring them to market quickly.

Learn More

Industrial Enzymes

Go from gene discovery to commercial manufacturing using the same host microorganism. Use Dyadic enzymes for large-scale production of innovative products. Dyadic delivers the C1 platform technology and more than 50 enzyme products to customers worldwide.

Learn More

BiofuelsBiochemicalsBiopharmaceuticalsAnimal FeedPulp and PaperTextilesFood and BeverageNutraceuticals

Welcome to Dyadic. We are a global biotechnology company with patented and proprietary technologies that are used to discover, develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries. Dyadic’s C1 platform technology enables the development and large scale manufacture of low cost enzymes and other proteins for diverse market opportunities. Dyadic leverages the value of its technologies through licensing arrangements and other collaborations with third parties who receive the benefits of producing and using the proteins these technologies help produce. LEARN MORE

Recent News

November 12, 2015
Dyadic Reports 3Q2015 Financial Results
Click Here
Audio Replay

November 10, 2015
Click Here
Audio Replay

Upcoming Events

Dyadic will hold a special meeting of stockholders on Friday December 11th, 2015 at 12:00 PM, New York City time, at the PGA National Resort & Spa, 400 Avenue of The Champions, Palm Beach Gardens, FL 33418
Dyadic Proxy Statement 11-16-15
2015 Special Meeting of Shareholders: VOTING


SNNLive Interview with Mark Emalfarb, CEO and Founder, Dyadic International, Inc
October 2015

Mark Emalfarb Presentation at 2015 BIO World Congress in Montreal
July 19-22, 2015

Mark Emalfarb Interview at LD Micro VI
Los Angeles, December 3-5, 2013